Alpha 2.0
Login Register
» Authors » Kathryn C Edwards

Kathryn C Edwards

Explore the profile of Kathryn C Edwards including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 1019
Followers 0
Related Specialties
Public Health
Psychiatry
Biochemistry
Top 10 Co-Authors
Andrew Hyland
Heather L Kimmel
Nicolette Borek
Cassandra A Stanton
Maciej L Goniewicz
Lisa D Gardner
Kristie A Taylor
Michael J Halenar
K Michael Cummings
Maansi Bansal-Travers
Published In
Nicotine Tob Res
Tob Control
Cancer Epidemiol Biomarkers Prev
Int J Environ Res Public Health
JAMA Netw Open
Affiliations
Soon will be listed here.
Recent Articles
1.
Correction to: Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in waves 1 through 5 (2013-2019) of the population assessment of tobacco and health (PATH) study
Paulin L, Halenar M, Edwards K, Lauten K, Stanton C, Taylor K, et al.
Respir Res . 2025 Mar; 26(1):93. PMID: 40057741
No abstract available.
2.
Functionally important respiratory symptoms and continued cigarette use versus e-cigarette switching: population assessment of tobacco and health study waves 2-6
Sargent J, Lauten K, Edwards K, Tanski S, MacKenzie T, Paulin L, et al.
EClinicalMedicine . 2025 Feb; 79:102951. PMID: 39968205
Background: Substitution of noncombustible tobacco products for cigarettes could improve respiratory symptoms. We hypothesized that complete cigarette-to-e-cigarette switching would improve respiratory symptoms compared to continued smoking. Methods: Longitudinal analysis of...
3.
Corrigendum to "Tobacco Product Use and Functionally Important Respiratory Symptoms Among US Adolescents/Young Adults" [Acad Pediatr. 2022; 22(6):1006-1016]
Tanski S, Halenar M, Edwards K, Emond J, Woloshin S, Brunette M, et al.
Acad Pediatr . 2025 Feb; 25(3):102561. PMID: 39922078
No abstract available.
4.
Corrigendum to "Cardiovascular disease outcomes among established cigar users 40 years and older: Findings from the population assessment of tobacco and health (PATH) study, Waves 1-5 (2013-2019)" [Pre. Med. Rep. 37 (2024) 102569]
Sharma E, Tang Z, Lauten K, Silveira M, Delnevo C, Edwards K, et al.
Prev Med Rep . 2025 Feb; 49:102941. PMID: 39897106
[This corrects the article DOI: 10.1016/j.pmedr.2023.102569.].
5.
Correction: Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Edwards K, Khan A, Sharma E, Wang L, Feng J, Blount B, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):206. PMID: 39780623
No abstract available.
6.
Correction: Urinary Cotinine and Cotinine + Trans-3'-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013-2014)
Edwards K, Naz T, Stanton C, Goniewicz M, Hatsukami D, Smith D, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):208. PMID: 39780622
No abstract available.
7.
Correction: Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014)
Cheng Y, Reyes-Guzman C, Christensen C, Rostron B, Edwards K, Wang L, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):209. PMID: 39780620
No abstract available.
8.
Correction: Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users- Results from Wave 1 PATH Study
Christensen C, Chang J, Rostron B, Hammad H, van Bemmel D, Del Valle-Pinero A, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):207. PMID: 39780619
No abstract available.
9.
Urinary anatalline and nicotelline cut-points to distinguish between exclusive and dual use of tobacco products
Edwards K, St Helen G, Jacob 3rd P, Ozga J, Stanton C
Biomarkers . 2024 Aug; 29(6):352-360. PMID: 39105562
Objective: This study measured anatalline and nicotelline, two minor tobacco alkaloids, to discriminate between exclusive smokeless tobacco (SLT) use, exclusive electronic nicotine delivery systems (ENDS) use, exclusive cigarette use, dual...
10.
Authors' Response to "Are Fourth Generation E-cigarettes Reducing Disease in the Population?"
Kasza K, Tang Z, Seo Y, Benson A, Creamer M, Edwards K, et al.
Nicotine Tob Res . 2024 Jun; 26(12):1756-1757. PMID: 38912851
No abstract available.